Grants and donations

Our Commitment

Shionogi is committed to advancing patient care by developing innovative, high-quality medicines that address unmet medical needs and improve quality of life. Our grants and donations program supports this mission by funding healthcare organizations, research initiatives, and educational programs that benefit patients and the broader medical community.

Eligibility and Focus Areas

Who Can Apply

 

We consider applications from:

- Healthcare organisations

- Patient advocacy groups

- Educational institutions

- Research organisations

- Medical societies

 

Applications must be from organisations based in Europe and comply with local pharmaceutical codes of practice, regulatory requirements, and applicable laws.

Therapeutic Areas

Priority is given to projects in our areas of expertise:

  • - Infectious diseases
  • - Central nervous system disorders (such as dementia and sleep disorders),
  • - Rare and orphan conditions
  • - Respiratory diseases  

Supported Activities

We fund initiatives that advance:

Healthcare improvement - Programs that enhance patient care delivery 

Medical education - Training and educational programs for healthcare professionals 

Patient education - Resources and programs that improve patient understanding and outcomes

Application Process

Review Criteria

Applications are evaluated based on:

  • - Scientific merit and innovation
  • - Potential impact on patient care
  • - Alignment with Shionogi's therapeutic focus areas
  • - Compliance with regulatory requirements
  • - Organisational credibility and capability

Decision Making

  • - Applications are reviewed impartially by the Shionogi Grants and Donations Committee
  • - Decisions are made at Shionogi's sole discretion and are final
  • - Priority is given to applications with the most significant positive impact on patient care
  • - All applications must comply with relevant national pharmaceutical codes of practice, which can be found on the EFPIA website

Budget and Timeline

Applications are reviewed on a rolling basis, subject to available funding.

Data Protection and Privacy

Information Use
Details about how Shionogi processes your personal data are outlined in our Privacy Notice. By submitting an application, you consent to the processing of your personal data for the purposes of evaluating and administering grants and donations.
Data Retention
  • Successful applications: Information is securely stored in accordance with local pharmaceutical codes, regulations, and legal requirements
  • Unsuccessful applications: Information is retained for two years following the determination date for audit and compliance purposes
  • All data is stored securely, and access is restricted to authorized personnel only

How to Apply

  • Standard Grants and Donations

    To submit an application for organizational grants or donations, complete our online application form.
    Click for details
  • Individual Sponsorship

    For sponsorship of individual Healthcare Professionals (HCPs) to attend educational meetings and congresses, contact:

     

    • - Your local Shionogi Key Account Manager
    • - Medical Science Liaison
    • - Regional Market Access Manager
  • Investigator Initiated Research (IIR)

    For research applications, contact your local Shionogi Medical Affairs representative or submit an online IIR application.

     

    What is IIR? Investigator Initiated Research is exploratory research conducted by qualified investigators who assume sponsor-investigator responsibilities in accordance with local health authority guidelines. These studies are unsolicited by Shionogi and derive from the academic research interests or clinical experience of independent investigators.

     
    Click for details

Contact Information

For questions about our grants and donations program:

Transparency and Compliance

Shionogi is committed to transparency in our funding activities. Details of grants and donations may be publicly disclosed in accordance with applicable pharmaceutical industry codes and regulations. All funded activities must comply with relevant ethical guidelines and regulatory requirements.
NP-EU-NP-0287 | September 2025